Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5236 to 5250 of 7685 results

  1. Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention to treat people on haemodialysis with ESA‑resistant anaemia?

    Recommendation ID NG203/23 Question Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention

    Research recommendation
    Published
    30 September 2021

  2. What is the long-term effect of laparoscopic cholecystectomy on outcomes that are important to patients?

    Recommendation ID CG188/5 Question What is the long-term effect of laparoscopic cholecystectomy on outcomes that are important to patients

    Research recommendation
    Published
    9 June 2015

  3. Impact of COVID-19: What is the medium-to long-term impact of the COVID-19 pandemic on children and young people's social, emotional and mental wellbeing?

    Recommendation ID NG223/11 Question Impact of COVID-19: What is the medium-to long-term impact of the COVID-19 pandemic on children and

    Research recommendation
    Published
    4 August 2022

  4. Risk tools for predicting non-sudden death in heart failure:- What is the most accurate prognostic risk tool in predicting 1-year mortality from heart failure at specific clinically relevant thresholds (for example, sensitivity, specificity, negative predictive value and positive predictive value at a threshold of 50% risk of mortality at 1 year)?

    Recommendation ID NG106/5 Question Risk tools for predicting non-sudden death in heart failure:- What is the most accurate prognostic risk

    Research recommendation
    Published
    19 December 2018

  5. Frequency of review:- What is the most clinical and cost-effective frequency of review for people on peritoneal dialysis, haemodiafiltration, haemodialysis or conservative management?

    Recommendation ID NG107/4 Question Frequency of review:- What is the most clinical and cost-effective frequency of review for people on

    Research recommendation
    Published
    18 December 2018

  6. Timing of pre-emptive transplant:- What is the most clinical and cost-effective strategy for timing of pre-emptive transplantation?

    Recommendation ID NG107/2 Question Timing of pre-emptive transplant:- What is the most clinical and cost-effective strategy for timing

    Research recommendation
    Published
    18 December 2018

  7. Interventions: What is the most clinically and cost‑effective management strategy for adults with calcific mitral stenosis and an indication for intervention?

    Recommendation ID NG208/21 Question Interventions: What is the most clinically and cost‑effective management strategy for adults with calcific

    Research recommendation
    Published
    16 December 2021

  8. Interventions for tricuspid regurgitation: What is the most clinically and cost-effective management strategy for adults with tricuspid regurgitation?

    Recommendation ID NG208/02 Question Interventions for tricuspid regurgitation: What is the most clinically and cost-effective management

    Research recommendation
    Published
    16 December 2021

  9. Managing acute hydrocephalus: What is the most clinically and cost-effective method of cerebrospinal fluid drainage or diversion (for example shunt surgery, external ventricular drain surgery or lumbar drain) for symptomatic acute hydrocephalus?

    Recommendation ID NG228/07 Question Managing acute hydrocephalus: What is the most clinically and cost-effective method of cerebrospinal

    Research recommendation
    Published
    12 December 2022

  10. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with asymptomatic severe heart valve disease (aortic regurgitation, mitral stenosis, mitral regurgitation or tricuspid regurgitation) and no current indication for intervention?

    Recommendation ID NG208/19 Question Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective

    Research recommendation
    Published
    16 December 2021

  11. Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective monitoring strategy (type and frequency of test) for adults with symptomatic moderate heart valve disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation and tricuspid regurgitation) and no current indication for intervention?

    Recommendation ID NG208/20 Question Monitoring when there is no current need for intervention: What is the most clinically and cost‑effective

    Research recommendation
    Published
    16 December 2021

  12. Monitoring when there is no current need for intervention: What is the most clinically and cost-effective monitoring (type and frequency of test) for adults with asymptomatic mild or moderate heart valve disease (aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation and tricuspid regurgitation) and no current need for intervention?

    Recommendation ID NG208/01 Question Monitoring when there is no current need for intervention: What is the most clinically and cost-effective

    Research recommendation
    Published
    16 December 2021

  13. What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?

    Recommendation ID NG131/4 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate

    Research recommendation
    Published
    7 January 2022

  14. Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration:- What is the most clinically and cost effective route of administration for NSAIDs in the management of acute pain thought to be due to renal or ureteric stones?

    Recommendation ID NG118/5 Question Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration:- What is the most clinically

    Research recommendation
    Published
    7 March 2019

  15. Laboratory tests to diagnose initial and ongoing infection and determine re-infection in the different presentations of Lyme disease in the UK:- What is the most clinically and cost-effective serological antibody-based test, biomarker or other test for diagnosing Lyme disease in the UK at all stages, including re-infection?

    Recommendation ID NG95/5 Question Laboratory tests to diagnose initial and ongoing infection and determine re-infection in the different

    Research recommendation
    Published
    27 November 2018